MAPT and Alzheimer disease: Lastly, it may be important to note that previous studies have found associations between eLORETA connectivity and disorder-specific biomarkers such as tau concentrations in Alzheimer’s disease [162] and neurocognitive measures such as MMSE [45], suggesting that EEG source connectivity methods may become a valuable diagnostic tool to detect/predict neuropsychiatric disorders.